BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35305234)

  • 1. A Systematic Review of Host Genomic Variation and Neuropsychological Outcomes for Pediatric Cancer Survivors.
    Kautiainen R; Aleksonis H; King TZ
    Neuropsychol Rev; 2023 Mar; 33(1):278-306. PubMed ID: 35305234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations among treatment-related neurological risk factors and neuropsychological functioning in survivors of childhood brain tumor.
    McCurdy MD; Rane S; Daly BP; Jacobson LA
    J Neurooncol; 2016 Mar; 127(1):137-44. PubMed ID: 26725098
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Kautiainen RJ; Keeler C; Dwivedi B; MacDonald TJ; King TZ
    Child Neuropsychol; 2022 Apr; 28(3):287-301. PubMed ID: 34448443
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of neuropsychological functioning in pediatric posterior fossa tumor survivors: Medulloblastoma, low-grade astrocytoma, and healthy controls.
    Levitch CF; Holland AA; Bledsoe J; Kim SY; Barnett M; Ramjan S; Sands SA
    Pediatr Blood Cancer; 2022 Feb; 69(2):e29491. PubMed ID: 34842359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Working memory training in survivors of pediatric cancer: a randomized pilot study.
    Hardy KK; Willard VW; Allen TM; Bonner MJ
    Psychooncology; 2013 Aug; 22(8):1856-65. PubMed ID: 23203754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing neurocognitive late effects in childhood leukemia survivors using a combination of neuropsychological and cognitive neuroscience measures.
    Van Der Plas E; Erdman L; Nieman BJ; Weksberg R; Butcher DT; O'connor DL; Aufreiter S; Hitzler J; Guger SL; Schachar RJ; Ito S; Spiegler BJ
    Child Neuropsychol; 2018 Nov; 24(8):999-1014. PubMed ID: 29017430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Neurological Predictor Scale: A predictive tool for long-term core cognitive outcomes in survivors of childhood brain tumors.
    Taiwo Z; Na S; King TZ
    Pediatr Blood Cancer; 2017 Jan; 64(1):172-179. PubMed ID: 27566994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral processing speed as a key mechanism in the relationship between neurological risk and adaptive functioning in survivors of pediatric brain tumors.
    Semmel ES; Quadri TR; King TZ
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28575. PubMed ID: 32813316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between visual working memory and visual attention among survivors of pediatric acute lymphoblastic leukemia (ALL) and their healthy peers.
    Treviño M; Breitmeyer BG; Ris MD; Fletcher JM; Kamdar K; Okcu MF; Parke EM; Raghubar KP
    J Clin Exp Neuropsychol; 2019 Nov; 41(9):974-986. PubMed ID: 31327287
    [No Abstract]   [Full Text] [Related]  

  • 10. Slower processing speed after treatment for pediatric brain tumor and acute lymphoblastic leukemia.
    Kahalley LS; Conklin HM; Tyc VL; Hudson MM; Wilson SJ; Wu S; Xiong X; Hinds PS
    Psychooncology; 2013 Sep; 22(9):1979-86. PubMed ID: 23447439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical fitness and neurocognitive outcomes in adult survivors of childhood acute lymphoblastic leukemia: A report from the St. Jude Lifetime cohort.
    Phillips NS; Howell CR; Lanctot JQ; Partin RE; Pui CH; Hudson MM; Robison LL; Krull KR; Ness KK
    Cancer; 2020 Feb; 126(3):640-648. PubMed ID: 31631333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodevelopmental model of long-term outcomes of adult survivors of childhood brain tumors.
    King TZ; Ailion AS; Fox ME; Hufstetler SM
    Child Neuropsychol; 2019 Jan; 25(1):1-21. PubMed ID: 28956496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Processing efficiency in pediatric cancer survivors: A review and operationalization for outcomes research and clinical utility.
    Trapani JA; Murdaugh DL
    Brain Behav; 2022 Dec; 12(12):e2809. PubMed ID: 36330565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late effects of pediatric brain tumors.
    Rey-Casserly C; Diver T
    Curr Opin Pediatr; 2019 Dec; 31(6):789-796. PubMed ID: 31693589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor functioning and associated cognitive outcomes in pediatric survivors of acute lymphoblastic leukemia.
    Oswald KA; Bo J
    Child Neuropsychol; 2020 Jul; 26(5):597-611. PubMed ID: 31594450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved neuropsychological outcomes following proton therapy relative to X-ray therapy for pediatric brain tumor patients.
    Gross JP; Powell S; Zelko F; Hartsell W; Goldman S; Fangusaro J; Lulla RR; Smiley NP; Chang JH; Gondi V
    Neuro Oncol; 2019 Jul; 21(7):934-943. PubMed ID: 30997512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognition, psychosocial functioning, and health-related quality of life among childhood cancer survivors.
    Siegwart V; Benzing V; Spitzhuettl J; Schmidt M; Grotzer M; Steinlin M; Leibundgut K; Roebers C; Everts R
    Neuropsychol Rehabil; 2022 Jul; 32(6):922-945. PubMed ID: 33208044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural Underpinnings of Working Memory in Adult Survivors of Childhood Brain Tumors.
    King TZ; Na S; Mao H
    J Int Neuropsychol Soc; 2015 Aug; 21(7):494-505. PubMed ID: 26234757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in survivors of pediatric medulloblastoma: a systematic review and meta-analysis.
    Baqai MWS; Tariq R; Shah Z; Bajwa MH; Shamim MS
    Childs Nerv Syst; 2023 May; 39(5):1159-1171. PubMed ID: 36826523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.